Loading…
SCYNEXIS, Inc. is projected to rise to $4.88 by 2027, a +1% move from its current price of $4.84. SCYX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $4.62 | $4.84 | $5.07 | +0.05% |
| Aug 4 | $4.54 | $4.84 | $5.17 | +0.10% |
| Aug 5 | $4.47 | $4.85 | $5.25 | +0.14% |
| Aug 6 | $4.42 | $4.85 | $5.32 | +0.19% |
| Aug 7 | $4.38 | $4.85 | $5.38 | +0.24% |
| Aug 8 | $4.33 | $4.85 | $5.44 | +0.29% |
| Aug 9 | $4.30 | $4.86 | $5.49 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.30 | $4.86 | $5.49 | +0.34% |
| Week 2 | $4.10 | $4.87 | $5.79 | +0.68% |
| Week 3 | $3.96 | $4.89 | $6.04 | +1.02% |
| Week 4 | $3.84 | $4.91 | $6.27 | +1.36% |
| Week 5 | $3.74 | $4.92 | $6.47 | +1.70% |
| Week 6 | $3.66 | $4.94 | $6.66 | +2.04% |
| Week 7 | $3.59 | $4.96 | $6.85 | +2.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SCYNEXIS, Inc. is a biotechnology company that focuses on drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence.
It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. Incorporated in 1999 and headquartered in Jersey City, New Jersey, SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc.
and changed its name to SCYNEXIS, Inc. in June 2002.
SCYNEXIS, Inc. (SCYX) currently trades at $4.84 per share, with a market cap of $384.5M and a rank of 3223. The stock sits within a near-term technical setup that can influence trading momentum, and it offers context for judging price prospects.
The near-term technical picture uses RSI, moving averages, and key support/resistance levels to frame potential moves.
A major floor 86.4% below — a decisive break under it would weaken the trend.
The nearest floor, 26.2% below — buyers have tended to step in here.
Price is pressing into resistance (1.9% away) — a breakout level to watch.
A major ceiling 20.0% above — clearing it would confirm fresh momentum.
Key SCYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SCYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.91 | Buy | $4.12 | Buy |
| MA 10 | $3.91 | Buy | $4.06 | Buy |
| MA 20 | $4.25 | Buy | $4.07 | Buy |
| MA 50 | $3.86 | Buy | $3.62 | Buy |
| MA 100 | $2.39 | Buy | $2.83 | Buy |
| MA 200 | $1.54 | Buy | $2.06 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.63 | Neutral |
| Stoch RSI (14) | 82.39 | Sell |
| CCI (20) | 97.67 | Neutral |
| Williams %R (14) | -6.62 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | 0.21 | Buy |
| Bollinger %B (20,2) | 0.83 | Neutral |
| Stochastic %K (14) | 93.38 | Sell |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | -0.24 | Sell |
| Ultimate (7,14,28) | 67.42 | Neutral |
| Momentum (10) | 0.57 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 4.01 | Buy |
| ADX (14) | 19.81 | Neutral |
| ATR (14) | 0.23 | Info |
The current technical sentiment is BULLISH. The RSI14 stands at 60, with a 50-day simple moving average of $4.45 and a 200-day simple moving average of $5.73. Key near-term support sits at $3.57 and resistance at $4.93.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.57 | $4.84 | $7.04 | 0% | Neutral | |
| $3.65 | $4.88 | $7.03 | +1% | Neutral | |
| $3.57 | $5.03 | $7.67 | +4% | Neutral | |
| $3.14 | $4.62 | $7.38 | -4% | Neutral | |
| $2.84 | $4.35 | $7.20 | -10% | Neutral | |
| $3.46 | $5.50 | $9.39 | +14% | Neutral | |
| $3.64 | $5.98 | $10.51 | +24% | Bullish | |
| $3.87 | $6.57 | $11.84 | +36% | Bullish | |
| $4.21 | $7.37 | $13.58 | +52% | Bullish | |
| $3.50 | $6.33 | $11.91 | +31% | Bullish | |
| $4.57 | $9.55 | $19.62 | +97% | Bullish | |
| $6.17 | $13.70 | $31.52 | +183% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.57 | $4.84 | $6.01 | +0.00% |
| September 2026 | $3.99 | $4.81 | $6.04 | -0.57% |
| October 2026 | $4.14 | $5.06 | $6.46 | +5.08% |
| November 2026 | $4.37 | $5.39 | $6.98 | +6.57% |
| December 2026 | $4.31 | $5.37 | $7.04 | -0.38% |
Click any year to see its month-by-month SCYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SCYX is projected to trade between $3.57 and $7.04, averaging $4.84 — a potential gain of 0% from today's $4.84. Price action looks broadly range-bound.
SCYNEXIS, Inc.'s 2027 outlook centres on $4.88, within a $3.65 to $7.03 range. That is up +1% on the projected 2026 average. That marks a +1% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, SCYX could reach as high as $7.67, with a base case around $5.03 and support toward $3.57 — roughly +4% from $4.84. Price action looks broadly range-bound.
Expect SCYX to range from $3.14 to $7.38 through 2029. The $4.62 average target implies a -4% move from current prices. That is -8% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The SCYX price prediction for 2030 points to an average of $4.35 (low $2.84, high $7.20) — a potential decline of -10% on today's $4.84. Price action looks broadly range-bound.
In 2031, SCYX is projected to trade between $3.46 and $9.39, averaging $5.50 — a potential gain of +14% from today's $4.84. That is up +26% on the projected 2030 average. A consolidation phase looks the most probable path here.
SCYNEXIS, Inc.'s 2032 outlook centres on $5.98, within a $3.64 to $10.51 range. That is up +9% on the projected 2031 average. That marks a +24% change versus current levels. Momentum favours further upside here.
By 2033, SCYX could reach as high as $11.84, with a base case around $6.57 and support toward $3.87 — roughly +36% from $4.84. Buyers look set to stay in control over this stretch.
Expect SCYX to range from $4.21 to $13.58 through 2034. The $7.37 average target implies a +52% move from current prices. That is up +12% on the projected 2033 average. Momentum favours further upside here.
The SCYX price prediction for 2035 points to an average of $6.33 (low $3.50, high $11.91) — a potential gain of +31% on today's $4.84. Buyers look set to stay in control over this stretch.
In 2040, SCYX is projected to trade between $4.57 and $19.62, averaging $9.55 — a potential gain of +97% from today's $4.84. That is up +51% on the projected 2035 average. Momentum favours further upside here.
SCYNEXIS, Inc.'s 2050 outlook centres on $13.70, within a $6.17 to $31.52 range. That is up +44% on the projected 2040 average. That marks a +183% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in SCYX today (≈ 206.61157 SCYX) could be worth
$2,831.54
+$1,831.54 (+183%) by 2050 · US Dollar
Based on the average projected SCYX price of $13.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SCYXwould be worth at today's price.
$1,000 invested in SCYX on Jul 31, 2025 (≈ 1,449.275367 SCYX) would be worth
$7,014.49
+$6,014.49 (+601.4%) today · 7.01× · US Dollar
Based on a SCYX entry price of $0.69 vs. today's $4.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.73 | $1,297.59 | +29.8% |
| 1 month ago | $4.23 | $1,144.21 | +14.4% |
| 3 months ago | $0.99 | $4,888.89 | +388.9% |
| 6 months ago | $0.741 | $6,531.71 | +553.2% |
| 1 year ago | $0.69 | $7,014.49 | +601.4% |
| All time (5.0y) ago | $6.91 | $700.43 | -30.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SCYX forecast.
Our base-case forecast reaches $9.70 around 2050.
Implied market cap at $9.70: $770.59M
The multi-year forecast shows a path of evolving value. For 2026, the min is $3.57, the avg is $4.84, the max is $7.04, with ROI 0 and a NEUTRAL sentiment. In 2027, the min is $3.65, the avg is $4.88, the max is $7.03, ROI 0.8, NEUTRAL.
2028 projects min $3.57, avg $5.03, max $7.67, ROI 3.9, NEUTRAL. 2029 shows min $3.14, avg $4.62, max $7.38, ROI -4.5, NEUTRAL. 2030 shows min $2.84, avg $4.35, max $7.20, ROI -10.1, NEUTRAL.
After a springboard into 2031 with min $3.46, avg $5.50, max $9.39, ROI 13.6, NEUTRAL, the forecast turns more bullish from 2032 onward: 2032 min $3.64, avg $5.98, max $10.51, ROI 23.6, NEUTRAL; 2033 min $3.87, avg $6.57, max $11.84, ROI 35.8, NEUTRAL; 2034 min $4.21, avg $7.37, max $13.58, ROI 52.2, NEUTRAL; 2035 min $3.50, avg $6.33, max $11.91, ROI 30.7, NEUTRAL. The uptrend continues with 2040 min $4.57, avg $9.55, max $19.62, ROI 97.2, NEUTRAL, and culminates in 2050 min $6.17, avg $13.70, max $31.52, ROI 183.2, BULLISH.
Tap a question to reveal the answer.
The 2030 forecast shows min $2.84, avg $4.35, max $7.20 with ROI -10.1% and sentiment NEUTRAL.
Forecasts show a neutral stance through 2026–2031, followed by a bullish outlook in later years, with 2050 average $13.70, max $31.52 and ROI 183.2% (sentiment BULLISH for 2050).
No. The 2030 max in the forecast is $7.20.
The 30-day range is $3.57 to $6.57.
2050 min $6.17, avg $13.70, max $31.52, ROI 183.2%, sentiment BULLISH.
SCYNEXIS, Inc. Community Discussion
0Share your SCYNEXIS, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.